Eversept Partners »

Agios Pharmaceuticals shares owned by Eversept Partners

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.8M 200k 33.83

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
GSK Sponsored Adr (GSK)
Vera Therapeutics Cl A (VERA)
Natera (NTRA)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Qiagen Nv Ord Shares (QGEN)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Hca Holdings (HCA)

View all positions for Eversept Partners

Top funds holding Agios Pharmaceuticals

Armistice Capital
BlackRock
Farallon Capital Management
State Street Corporation
D. E. Shaw & Co
Vanguard Capital Management
Lynx1 Capital Management
Vanguard Portfolio Management
Erste Asset Management GmbH
Bnp Paribas Investment Partners
Susquehanna International
Nomura Asset Management International
Geode Capital Management
MPM Oncology Impact Management
Frazier Life Sciences Management

View all funds holding Agios Pharmaceuticals